New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 29, 2014
09:17 EDTADMPAdamis Pharmaceuticals announces FDA acceptance of NDA for Epinephrine Injection
Adamis Pharmaceuticals announced that the FDA has accepted for review its New Drug Application, or NDA, for the product, Epinephrine Injection PFS, for the emergency treatment of allergic reactions including anaphylaxis.
News For ADMP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 17, 2014
17:07 EDTADMPAdamis Pharmaceuticals files to sell 2.84M shares of common stock for holders
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use